Yvonne Li

Yvonne Li is an experienced finance professional currently serving as the Interim Chief Financial Officer at Senti Biosciences since 2024 and is a member of the Biotech CFO Sisterhood. Prior to this role, Yvonne held the position of Chief Administrative Officer and Senior Vice President of Finance at Nkarta Therapeutics, Inc. from 2019 to 2023. Yvonne's extensive background in finance includes serving as Senior Vice President of Finance at Amunix Pharmaceuticals and as Vice President of Finance and Principal Financial & Accounting Officer at OncoMed Pharmaceuticals from 2007 to 2019. Earlier career roles include Director of Accounting at AnitaB.org and Finance Manager at Questra Corporation. Yvonne holds a Master of Business Administration in Finance from San Francisco State University and a Bachelor of Arts from National Taiwan Normal University.